Recent publications published by researchers at the MRC WIMM.
Multi-organ abnormalities assessed by a single MRI scan in individuals with blood cancer.
Reed S. et al, (2024), Eur J Intern Med
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Chowdhury O. et al, (2021), Br J Haematol, 194, 1010 - 1015
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide.
Chowdhury O. et al, (2021), Leukemia, 35, 1197 - 1202
Evaluation of the detection of B-cell clonal lymphoproliferative disorders by flow cytometry or cytological analysis in lymph node aspirates obtained by endobronchial ultrasound
Lomas O. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 93 - 94
Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide
Chowdhury O. et al, (2018), BLOOD, 132
Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.
Mead AJ. et al, (2017), J Exp Med, 214, 2005 - 2021
Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.
Watson AS. et al, (2015), Cell Death Discov, 1
Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo, [Cancer Cell, 25, 2014, 794-808]
Woll PS. et al, (2015), Cancer Cell, 27, 603 - 605
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
Svensson T. et al, (2014), Eur J Haematol, 93, 439 - 445
Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]
Woll PS. et al, (2014), Cancer Cell, 25
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
Woll PS. et al, (2014), Cancer Cell, 25, 794 - 808
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
Woll PS. et al, (2014), Cancer Cell, 25, 794 - 808
THIRD GENERATION AUTOLOGOUS MYELOID-DERIVED DENDRITIC CELLS DEVELOPED FROM PATIENTS WITH CMML AND MDS DEMONSTRATE PHENOTYPIC PROPERTIES OF MATURE FUNCTIONAL DENDRITIC CELLS
Anderson K. et al, (2014), CYTOTHERAPY, 16, S24 - S25
THIRD GENERATION AUTOLOGOUS MYELOID-DERIVED DENDRITIC CELLS DEVELOPED FROM THE PATIENTS WITH CMML AND NON-CML SUBTYPES OF MDS DEMONSTRATE PHENOTYPIC PROPERTIES OF MATURE FUNCTIONAL DC
Anderson K. et al, (2014), BONE MARROW TRANSPLANTATION, 49, S138 - S138
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine
Svensson T. et al, (2014), European Journal of Haematology, 93, 439 - 445
Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML
Chowdhury O. et al, (2014), BLOOD, 124
FLT3-ITD INDUCED MYELOPROLIFERATION CAUSES A CELL EXTRINSIC DEPLETION OF HAEMATOPOIETIC STEM CELLS
Mead AJ. et al, (2014), HAEMATOLOGICA, 99, 256 - 256
Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.
Sanjuan-Pla A. et al, (2013), Nature, 502, 232 - 236
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
Fisher SA. et al, (2013), Cochrane Database of Systematic Reviews, 2017